Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-20

Clinical Trial Update: Surveillance of Humira Injection in Korean Patients

View source ↗

Summary

Results from a completed clinical trial evaluating Humira (adalimumab) in Korean patients with rheumatoid arthritis, psoriatic arthritis, and related conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Status: COMPLETED | Results posted: 2013-08-20